Related Experiment Video
Updated: May 17, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
The pathogenesis of pulmonary fibrosis: a moving target
Wim A Wuyts1, Carlo Agostini, Katerina M Antoniou
1Laboratory of Pneumology, Dept of Respiratory Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. wim.wuyts@uzleuven.be
Abstract:
Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is characterised by excessive matrix formation leading to destruction of the normal lung architecture and finally death. Despite an exponential increase in our understanding of potentially important mediators and mechanisms, the delineation of primary pathways has proven to be elusive. In this review susceptibility and injurious agents, such as viruses and gastro-oesophageal reflux, and their probable role in initiating disease will be discussed. Further topics that are elaborated are candidate ancillary pathways, including immune mechanisms, oxidative and endoplasmic reticulum stress, activation of the coagulation cascade and the potential role of stem cells. This review will try to provide the reader with an integrated view on the current knowledge and attempts to provide a road map for future research. It is important to explore robust models of overall pathogenesis, reconciling a large number of clinical and scientific observations. We believe that the integration of current data into a "big picture" overview of fibrogenesis is essential for the development of effective antifibrotic strategies. The latter will probably consist of a combination of agents targeting a number of key pathways.
Insights
Pulmonary fibrosis, a fatal lung disease, involves excessive matrix buildup. This review explores initiating factors and pathways, aiming to guide research toward effective combination antifibrotic therapies.
Area of Science:
- Pulmonary medicine
- Pathology
- Cell biology
Background:
- Pulmonary fibrosis represents the end-stage of various diffuse parenchymal lung diseases.
- It is characterized by aberrant matrix deposition, leading to irreversible lung architecture destruction and mortality.
- Despite advances, the primary pathogenic pathways remain incompletely understood.
Purpose of the Study:
- To review current knowledge on pulmonary fibrosis pathogenesis.
- To discuss initiating factors, including viral infections and gastro-oesophageal reflux.
- To explore ancillary pathways such as immune responses, stress pathways, coagulation, and stem cell involvement.
Main Methods:
- This is a review article, synthesizing existing scientific literature.
- It integrates clinical observations with mechanistic insights.
- Focuses on identifying key pathways in fibrogenesis.
Main Results:
- Susceptibility and injurious agents are proposed as initiating factors.
- Immune mechanisms, oxidative stress, endoplasmic reticulum stress, coagulation, and stem cells are discussed as ancillary pathways.
- An integrated view of fibrogenesis is presented.
Conclusions:
- Understanding the complex interplay of initiating and ancillary pathways is crucial for advancing pulmonary fibrosis research.
- Developing effective antifibrotic strategies will likely require targeting multiple key pathways simultaneously.
- A comprehensive "big picture" overview is essential for guiding future therapeutic development.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cirrhosis II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Inflammation: Introduction

